Member Info for TedB

And don't forget we will be selling 100,000 treatments per month at $3,000 a pop from January. That's roughly £250 million a month turnover.

Fair summary and good follow up advice. Thanks Saxon.

I hope you are right Enrico because Marsden said very straight in the ShareSoc broadcast that a successful vaccine could completely undermine his forecasts for 2021. If he is still selling 100,000 treatments a month for 2021 and 2022 I will be over the moon. And financially very secure.

Such happy days, Eva. How we laughed when Griffiths, Venrock and Licht dumped their shares. What silly billies they were.

Sharedealer, indeed I have often noticed the strange coincidence of sales tending to involve both a seller and a buyer. What surprised was a) the price itself, b) that such a relatively high price was recorded as a sale, and c) that it was registered at 07.28 with today's date. I assume a late report from yesterday would carry yesterday's date

Registered as a sell!!!! at 07.28 this morning.

Marsden was. Have a look at his recent presentation on ShareSoc. The bit where he comments on the effect of a successful vaccine on his SNG forecast for 2021.

Nice one, Oxford

Not me Bors. I'm waiting to see what today's Lancet says first.

Donot, got the same thing just now on HL. Sometimes it's tempting.....

HL now offering 186.02 to sell and 186.24 to buy

Has anyone checked the Stock Exchange site? There seem to have been several huge "minus" trades posted in the past few minutes. No idea what's going on.

Manifesto, I started topping up as soon as RM mentioned going to shareholders in his last video. I did not think it would be offered to PIs. Final top up last week at 191 after the RNS. It is only about 10% above the price we can buy at in the offer. Just thought I would get on with it. Fingers still crossed for next 12 months.

Manifesto, love weird days like today. On HL I have just been offered 186.66 to sell and 186.5 to buy. Sadly already topped up my 30% to cover the dilution.

For info, this was recently published in the FT - Remdesivir has little effect on Covid-19 mortality, WHO study says
Results of highly anticipated Solidarity trial strike a blow to hopes for coronavirus treatments

Cheers, pmjh, might have a decent pension after all......

pmjh, Aurélien Mary MD, at CHU Aliens has a trial of interferon beta 1b listed on clinical trials.gov - Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study. The last update was, I think, 20th July. Is this the guy who tweeted about French approval for SNG001 as of 15th?. Even if his trial is beta 1b he must know what's going on?

The agenda is available on line if you google - EMA meeting 15 October 2020. I did a search but found no reference to Synairgen or SNG001. The only interferon on the list is from Biogen Netherlands. Does not necessarily mean SNG is not being discussed; there is a note that, for commercial confidentiality reasons, not all agenda information is published.

Gkb, tells me I should have paid more attention.....

LSE is showing the 243,534 shares traded for £1.63 each at 17.11 as a " sale " !!!